Specialty probe developer Neoprobe of Dublin, OH, has received 510(k) clearance from the Food and Drug Administration for a new version of its Quantix/OR probe.
Neoprobe said the probe had been redesigned to enhance visual ergonomics, and to make it easier for surgeons to use. One benefit, for example, is that surgeons can now use the probe to access vessels for measurement during both on- and off-pump bypass procedures, according to the company.
Neoprobe reintroduced Quantix/OR at a surgical society meeting in Hamburg last weekend, and plans a full product re-introduction at the American Association for Thoracic Surgery conference in April.
By AuntMinnie.com staff writersFebruary 15, 2005
Related Reading
Neoprobe extends Japanese distribution deal, August 25, 2004
Neoprobe reports Q1 results, May 13, 2004
Neoprobe trims losses in 2003, March 9, 2004
Neoprobe hires Linder, October 27, 2003
Neoprobe gets go-ahead for Quantix/OR, September 9, 2003
Copyright © 2005 AuntMinnie.com
